Literature DB >> 18428601

Immunoblotting and immunodetection.

Sean Gallagher1, Scott E Winston, Steven A Fuller, John G R Hurrell.   

Abstract

Immunoblotting (western blotting) is used to identify specific antigens recognized by polyclonal or monoclonal antibodies. This unit provides numerous protocols for all steps starting with solubilization of the protein samples, usually with SDS and reducing agents. Following solubilization, the material is separated by SDS-PAGE and the antigens are then electrophoretically transferred to a membrane, a process that can be monitored by reversible staining or Ponceau S staining. The transferred proteins are bound to the surface of the membrane, providing access to immunodetection reagents. Any remaining binding sites are blocked by immersing the membrane in a blocking solution. After probing with the primary antibody, the membrane is washed and the antibody-antigen complexes are identified with horseradish peroxidase (HRPO) or alkaline phosphatase enzymes coupled to the secondary anti-IgG antibody (e.g., goat anti-rabbit IgG) and appropriate chromogenic or luminescent substrates. Finally, membranes may be stripped and reprobed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18428601     DOI: 10.1002/0471142301.ns0519s29

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  2 in total

1.  Western blotting via proximity ligation for high performance protein analysis.

Authors:  Yanling Liu; Jijuan Gu; Åsa Hagner-McWhirter; Poojahrau Sathiyanarayanan; Mats Gullberg; Ola Söderberg; Johan Johansson; Maria Hammond; Daniel Ivansson; Ulf Landegren
Journal:  Mol Cell Proteomics       Date:  2011-08-02       Impact factor: 5.911

2.  Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.

Authors:  Fang He; Tanja K Kiener; Xiao Fang Lim; Yunrui Tan; Kattur Venkatachalam Ashok Raj; Manli Tang; Vincent T K Chow; Qingfeng Chen; Jimmy Kwang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.